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Summary
The majority of industrial enzymes available at present is used in food industry. Safe-
ty regulations of food enzymes differ among countries, including fundamental aspects,
whether a pre-market approval is needed and on the level of details, e.g. what particular
information manufacturers have to provide in the course of safety evaluation. Occupa-
tional safety concerns focus on allergenic properties as it is well established that enzymes
are potent inhalative sensitizers and can cause allergic reactions including asthma. Other-
wise toxic substances including bacterial toxins and mycotoxins might also be present in en-
zyme isolates and might thus constitute a safety risk to consumers. Safety evaluation pro-
cedures seem to be appropriate as no incidents have been reported so far, resulting in sug-
gestion for reduced test packages. Safety precaution and monitoring measures established
by industry have also reduced but not entirely eradicated occupational risks. Challenges
to regulators and industry arise from unresolved issues, e.g. whether enzymes might be
contact sensitizers, and from the lack of harmonisation of both legislation and safety eval-
uation. In the EU, most food enzymes are not covered by food safety regulations neither
on Community nor on national level. On top of this the availability of enzymes with new
and unusual properties raises questions of safety. In the EU there seems to be a chance
that these challenges will be tackled in the course of establishing a harmonised legislation
on food enzymes.
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Introduction
Industrial enzymes are a growing business world-
wide worth about two billion US$ – with food enzymes
capturing about half of it. While both the number of
available food enzymes and their annual turnover have
been steadily increasing for many years so has the num-
ber and kind of applications. As of 2001 the major in-
dustry association AMFEP (Association of Manufactu-
rers and Formulators of Enzyme Products) lists about
160 enzymes manufactured for use in food industry, at
least 36 of which were produced from genetically modi-
fied microorganisms (1). Most enzymes are applied in
the beverage industry, bakery industry, in the produc-
tion of dairy products and in the processing of starch.
In many cultural contexts various applications of en-
zyme producing microbes in food processing have been
practiced for centuries or even thousands of years. The
application of purified enzymes of microbial origin is a
rather recent invention that dates back to the first half of
the 20th century. Improvements in bioprocessing and
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strain development and especially the advent of genetic
engineering have greatly increased the availability of en-
zymes and tailoring of enzyme properties in order to meet
the sometimes very distinct requirements of the techni-
cal environments where they are used. As enzymes are
often used to replace steps in food processing encom-
passing harsh chemical or physical conditions (tempera-
ture, pressure, chemicals), they are frequently perceived
to be in line with both sustainable industrial production
and careful processing of food in order to maintain nu-
tritionally important ingredients such as vitamins, etc.
The rise of food enzymes as substances applied in
food processing has also captured the interests of regu-
lators in most industrialised countries. Newly marketed
food enzymes might need a prior market authorisation
by the US Food and Drug Administration (FDA) and –
if they are considered food additives – also by the Euro-
pean Food Safety Authority (EFSA). In addition, a small
number of EU Member States do have national legisla-
tions on food enzymes in place. These legislations main-
ly serve to ensure the safety of enzyme preparations for
the final consumers and sometimes include specifica-
tions for purity and activity. In certain cases occupa-
tional health issues that might arise from manufacturing
and handling enzymes are also part of the regulatory
overview.
Risks of allergic reactions in workers handling en-
zymes are not specific to enzymes and have been dis-
cussed at great length in the scientific literature, within
industry themselves and among stakeholders concerned,
and even made it to the general press. In fact, the occur-
rence of severe allergic responses in workers of deter-
gent enzyme manufacturers and allegedly also in con-
sumers of washing powders almost led to the collapse
of the enzyme industry between the late 1960s and early
1970s (reviewed in 2). Safety concerns for consumers
largely focus on toxic by-products that might be inad-
vertently present in the enzyme preparation and might
thereby be transferred to foodstuff.
Given the restricted scope of the EU food legislation
the former aspect has mainly been an issue in the con-
text of EU chemical legislation. Under chemical legisla-
tion occupational hazards have to be considered for both
notification of new substances and for classification and
labelling purposes as well.
Apart from the problems with enzyme dust 25 years
ago, enzymes have neither been a focal issue for regula-
tors nor for consumer groups or general public. In the
beginning of the 1990s this started to change when con-
sumer and environmental groups were alarmed by the
increasing use of genetically modified microorganisms
(GMM) for enzyme production. This eventually led to
reviews of safety concerns and regulatory aspects, espe-
cially in Germany, Switzerland and Austria (reviewed
in 2). Both environmental and health risks were dis-
cussed along with the benefits. However, enzymes from
GMM were soon superseded by other topical issues, es-
pecially the cultivation and use for food processing of
genetically modified crops. Beyond safety aspects in
terms of labelling and tracking of genetically modified
food as well as for organic agriculture, food enzymes
have continued to be an issue – at least for regulators
and food industry.
In the »back yards« of EU food authorities, however,
awareness has been growing that enzymes in general and
food enzymes in particular are not covered by appro-
priate regulations. Especially the exemption of almost
all food enzymes from any kind of mandatory regula-
tory overview have been perceived as problematic for
years. The accessibility of novel types of enzymes with
unusual properties and from exotic sources such as deep
sea and hot springs, and the use of certain techniques of
genetic engineering added to this problem (3,4) and
eventually led to a proposal for a harmonised EU legis-
lation on food enzymes. The debates that will take place
in the run-up to such legislation are likely to draw atten-
tion to food enzymes from several quarters beyond re-
gulators and industry – especially from consumer and
environmental organisations. Thus, safety and regula-
tory aspects of enzymes will not be discussed only in
terms of compliance costs and of harmonisation to faci-
litate free-trade. Given the consumer awareness of food
products and ingredients especially in the EU, it might
again be discussed in terms of safety. Thus, it might be
more than appropriate to review the status quo of food
enzymes in terms of legislation and safety aspects –
issues which might still be rather remote for University
scientists but might be much closer to the business of
enzyme manufacturing and food industry.
The first part of this review provides an overview
on the occupational health and consumer safety issues
associated with enzymes and enzyme production. The
regulatory frameworks and the bodies responsible for safe-
ty evaluation and market authorisation in the EU and
beyond are then described in the second part. The third
part briefly summarises the genetic engineering tech-
niques applied in enzyme manufacturing and a conclu-
ding part summarises and briefly discusses challenges
to regulators and industry.
Safety Concerns Associated with Enzymes
Safety concerns associated with industrial enzymes
in general are possible allergenic, irritative and other-
wise toxic properties. Allergenic and irritative risks are
mainly issues of occupational health in the industrial
production and application of enzymes, whereas risks of
oral toxicity are especially relevant to consumers of food
enzymes.
Allergenic and irritative properties
In occupational contexts enzyme exposure includes
mainly to dust or liquid aerosols that are set free while
handling enzyme preparation in either manufacturing of
the enzyme itself or using enzyme preparations in other
industrial contexts. This is generally true for all enzymes
regardless of the particular end-use.
The particles are deposited on the skin or on the mu-
cous membranes of the respiratory tract. When an en-
zyme comes into contact with the respiratory tract or
the skin, the body’s immune system may be stimulated
to produce antibodies resulting in respiratory allergy or
contact urticaria, respectively. And because skin has a
protein structure, enzymes which catalyse breakdown of
proteins such as proteases, are potential skin irritants.
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Immunologists differ between allergenic effects and
sensitization. The latter means that individuals who are
exposed to a possible antigen (here: the enzyme) for the
first time may develop antigen-specific IgG and/or IgE
antibodies. The formation of IgG indicates exposure, and
IgE antibodies indicate allergic sensitization but not al-
lergic disease. Thus, individuals with a positive skin prick
test or specific IgE in their blood would not necessarily
be considered ill. If sensitized individuals would, how-
ever, subsequently be exposed to the antigen, this might
result in an allergic response. So, the question is whe-
ther enzymes could be antigens, whether there is evi-
dence that enzymes can elicit allergic reactions and be
sensitizers, and eventually, if they can act as irritants to
the skin. Table 1 provides an overview of evidence on
these kinds of health effects.
Many allergens, especially in food and pollen, are
proteins. Whether a protein becomes an allergen depends
on a set of factors including structural features of the
protein. Several common allergens, e.g. from house dust
mites, storage mites, ragweed, pollens, Alternaria, cat dan-
der, and bee venoms, are furthermore proteins with en-
zymatic activity (5). And if common antigens are enzy-
mes by nature, enzymes may correspondingly represent
antigens. In fact, certain enzymes may also be more
prone to cause sensitisation than other proteins because
of their intrinsic capacity, e.g. the proteolytic function of
many of these allergens has been proposed to be an im-
portant factor in the epithelial permeability and the ori-
gin of allergy (6,7).
Many medical reports on allergenic and sensitizing
properties of enzymes come from the detergent indus-
try. In fact, it was the handling of enzyme containing
washing powders in the second half of the 1960s that
led to numerous reports of respiratory illnesses at the
workplace. By the early 1970s for every 1000 workers an
average of 400 were sensitised and 150 went on to de-
velop respiratory symptoms (8–10). Similar reports were
made in the enzyme manufacturing industry (e.g. 11 re-
viewed in 3). Since then the problem seems to have de-
creased, because the industry introduced quite extensive
measures to diminish and monitor the exposure of work-
ers, including encapsulation of enzymes, using immobi-
lised preparations, avoiding direct contact, introduction
of safe working practices and training of workers, re-
placement of older products by antigenically distinct pro-
teases, and exclusion of potentially pre-disposed and es-
pecially sensitive workers from directly working with
enzyme preparations (2).
The highest percentage of exposed people nowadays
seems to be affected in the bakery industry and in the
enzyme manufacturing industry, but sensitisation may
also occur in the animal feed industry, resulting in con-
cerns for meat consumers. Only recently several reports
have been published on allergic reactions in other occu-
pations (pharmaceutical industry, at laboratory work, etc.)
and even in consumers after dermal, mucosal, oral and
parenteral (injection, infusion) exposure to enzyme drugs,
enzymes in cosmetics, soaps, in soft lens fluids, in meat,
and other products of daily life (ref. 12 in Table 2).
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Table 1. Health impacts of enzymes in occupational settings reported in the scientific literature
Causative agent Exposure Health impact Evidence
Enzyme dust,
aerosols
Inhalation Immediate type allergic reactions (type I)
e.g. conjunctivitis, rhinitis, asthma
Good empirical evidence
Skin contact Immediate type allergic reactions (type I)
e.g. allergic contact urticaria
Good empirical evidence but lack of differen-
tiation from allergic contact dermatitis
Delayed type allergic reaction (type IV)




Skin irritation Literature reports from the 1970s, recent
reports missing
Food enzymes Ingestion Rare cases following respiratory sensitization





Starch processing and baking










amylases CA, CU RA
cellulases CA, CU RA
hemicellulases CA, CU RA
Protein industry
papain CA RA
pancreatic proteinase n.r. RA
Animal feed industry
cellulases CA, CU RA
hemicellulases CA, CU RA
proteases CA RA





Key: CA enzyme causing contact allergy, CU enzyme causing
contact urticaria, n.r. not reported, RA enzyme causing respi-
ratory allergy
In accordance to what is said above, reports from
the detergent, the baking and flour industry show that
most exposed workers produce IgG antibodies (13,14) and
several develop IgE antibodies (become sensitised) (15).
In bread producing factories, exposure rates are high and
enzymes have become a major cause of occupational dis-
ease. Recent reports have shown that of all the workers
in the industry who were sensitized after the exposure,
up to 36 % work in the enzyme manufacturing, up to 22
% in detergent industry, up to 30 % in the bakery indus-
try, and 31 % in the pharmaceutical industry. Lower rates
of sensitization were reported from the animal feed and
the textile industry (16,17). These numbers are strikingly
high despite the fact that industry – especially enzyme
and detergent manufacturing industry, has done a lot to
diminish worker exposure. However, only a minority of
sensitised workers ever get ill. Whereas symptoms are
usually mild, they are sometimes bothering enough and
hinder individuals to continue working with those en-
zymes.
Overlooking the literature, there is sufficient evi-
dence that enzymes can cause allergy, the main pro-
blems being allergies of the respiratory tract and, pro-
bably secondary, of the skin. In contrast, the question
whether enzymes cause primary skin sensitisation or
contact dermatitis directly is still controversially dis-
cussed: denied by some articles (18–21), but supported
by other publications (12,22,23). Beyond occupational risks
there is little evidence of any allergic risks to the final
consumers of enzyme containing products. A rare excep-
tion might be workers who were previously respiratory
sensitized with enzyme preparations and who might re-
act to food enzymes – even if the food were heat-treated
as in the case of bread (reviewed in 3).
Whether an enzyme in fact sensitises depends most-
ly on factors like the molecular structure and binding
capacities to certain reactive epitopes. Presently, no pre-
dictive tools exist that would allow for sufficiently reli-
able prediction of allergenic or de novo sensitizing pro-
perties of a given enzyme – especially in case when a
protein has not been part of the food chain before (24).
Differences between different regulatory contexts in co-
ping with these uncertainties seem to exist: the present
allergenicity assessment of introduced proteins in genet-
ically modified plants used for food purposes is largely
restricted to indirect evidence such as homology com-
parisons to known allergens and in vitro digestibility
tests simulating the gastrointestinal tract. In contrast, en-
zyme manufacturers that produce enzymes under the
EU chemical legislation have acknowledged that – in the
absence of any tests that could either predict or exclude
allergenic properties – enzymes are generally considered
as inhalative sensitizers and are handled and labelled
accordingly (2).
Beyond possible allergenic properties enzymes are
also supposed to be mild skin irritants in the workplace
(18). The extent of damage will mostly depend on the
time and intensity of exposure, the nature of the enzyme
(e.g. proteases might attack skin proteins) and its con-
centration, the integrity of the skin, and cofactors such
as additional detergent exposure, but controlled studies
from the past two decades are missing. Since the con-
centration of enzymes in end products is very low, irri-
tating properties are not considered a problem for con-
sumers. Validated animal models are available to routine
tests for irritative properties of the substances on skin
and eyes (25). A systematic adjustment of these methods
for high molecular mass substances such as proteins is
still missing.
Toxic properties
Allergenic properties of enzymes are intrinsic to the
structure of the enzyme protein (and possibly other pro-
teins present in the enzyme preparation). Toxic concerns
are, in contrast, rather focused on by-products and con-
taminants present in enzyme preparations. In the case of
food enzymes, these concerns are especially relevant for
obvious reasons. The range of the active enzyme in the
final product from the fermentation processes, the en-
zyme concentrate, varies significantly between 2 and 70
% – hence, by-products amount up to 98 % (AMFEP,
personal communication). These by-products are vary-
ing in terms of quantity and nature, depending on the
production organisms and the particular conditions of
the bioprocess. Toxic substances could result from con-
taminants during fermentation or from the production
organisms themselves. It is well known that some pro-
duction organisms or at least phylogenetically closely
related strains (same genus or same species) can – under
certain conditions – produce toxins (e.g. in the case of
certain bacteria and numerous filamentous fungi).
A recently updated review of about 30 toxicity eval-
uations of food enzymes published in the scientific liter-
ature did not reveal any toxic effects neither of enzymes
themselves nor of by-products. These evaluations include
acute, subacute, subchronic toxicity, and in vitro genoto-
xicity (Spök, unpublished results). These published tox-
icity evaluations in fact represent only a small portion of
toxicity evaluations conducted by the enzyme manufac-
turing industry. As of 2001 almost 800 toxicity tests con-
ducted on more than 180 enzymes have been reported
by AMFEP member companies alone. In addition to the
endpoints mentioned above these studies included occa-
sionally chronic toxicity, in vivo genotoxicity, reproduc-
tion (including teratogenicity), and in vitro cytotoxicity
(AMFEP, personal communication). According to AMFEP
these tests did not disclose toxic concerns.
In contrast to the overwhelming evidence about aller-
gic properties of enzymes there seems to be no correspon-
ding evidence of toxic effects of enzyme preparations
neither in occupational environments nor in consumers.
Generally concluding the absence of toxic risks in en-
zyme preparations might however be somehow prema-
ture. This may rather denote that present safety evalua-
tion procedures have so far been sufficient to detect
toxic contaminants before marketing of enzyme prepara-
tions.
Nevertheless, the possibility of toxic contaminants
in enzyme preparations is still widely acknowledged.
Thus, one of the most important factors in safety assur-
ance of enzyme preparations is the toxic and pathogenic
potential (26) and a reliable identification (e.g. including
DNA fingerprinting) of the microorganisms used along
with the quality assurance system to safeguard against
drift in taxonomy, mutations or selection of strains with
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unwanted abilities. Given the possibility that micro-
organisms belonging to the same species but different
strains might differ in their ability to produce toxins,
both quality assurance and identification have to be on
the strain level (27).
Secondly, changes in bioprocessing conditions such
as pH, temperature, purification process or media ingre-
dients might affect the nature and quantity of by-prod-
ucts – including possible toxins. According to Rassmus-
sen and Skovgaard (27) even microorganisms not known
to be harmful in food applications, might under differ-
ent conditions turn out to be toxin producers. Thus,
there is also a safety reason to thoroughly describe and
maintain the process conditions.
Furthermore, enzyme concentrates can be, and in
fact are, subjected to animal testing for a variety of toxi-
cological endpoints as described above. Besides, micro-
bial toxins that might occur as contaminants can be iden-
tified and measured. The latter are chemical analytical
tests that have to be conducted for each individual to-
xin, the former are intended to detect all (known and
unknown) toxins that might be present. Beyond toxic sub-
stances microbes might contaminate enzyme preparations
and even antibiotic substances might be present. Thus,
total viable counts are usually measured in enzyme pre-
parations and the presence of coliforms, Salmonella sp.,
E. coli, and pathogenic microorganisms is investigated (26).
What kind of toxicity relevant information should
be required is still contested in the scientific literature.
Pariza and Johnson (26) are advocating either acute or
14–91-day subchronic oral toxicity studies depending
largely on the species of the host organism and consid-
eration of the nature of toxins that could theoretically be
present (e.g. mycotoxins or bacterial enterotoxins). Other
authors, in contrast, are proposing 90-day studies only
(27). The latter is also suggesting mutagenicity testing
while the former is explicitly disregarding these kind of
tests largely because they have only revealed either neg-
ative or false positive so far. These differences are also
mirrored in the different guidelines for enzyme safety
evaluation as discussed in the following section of this
paper.
Regulatory Contexts and Requirements for
Safety Evaluations
In terms of food legislation enzymes have so far
been distinguished into food additives and processing
aids. The main distinction between food additives and
processing aids is that additives have a technological
function in the final food, whereas processing aids do
not (ref. 28 in Table 3). This distinction is important be-
cause in some jurisdictions a pre-market authorisation,
including safety evaluation, is mandatory for additives
only. The definitions underlying this distinction vary be-
tween jurisdictions. In Canada, USA and Japan for in-
stance, all food enzymes are regulated as food additives.
In Australia food enzymes are considered processing
aids. Also, the Joint FAO/WHO Expert Committee on
Food Additives (JECFA), which has been conducting vo-
luntary safety reviews on food enzymes since 1971, does
not differentiate between these categories.
In the EU food legislation the situation is more com-
plex. Most food enzymes are considered as processing
aids. So far, only two enzymes, lysozyme and invertase,
are considered as additives. Interestingly, this differenti-
ation was not followed by the European Commission’s
own Scientific Committee, the Scientific Committee on
Food (SCF), which was responsible for the evaluation of
food additives: from »a toxicological point of view it is
not pertinent to distinguish between [enzymes used as
processing aids or food additives] since, in both cases,
the enzyme preparations may remain in the food« (29).
A few enzymes are covered by the EU specialised legis-
lation, e.g. on winemaking. The majority of about 160
food enzymes produced/marketed in the EU are, how-
ever, considered as processing aids, the regulation of
which is still governed by national legislation – if there
is any legislation in place at all.
National regulations on enzymes used as processing
aids differ substantially among the EU Member States.
In France, Denmark, Poland and Hungary these enzymes
are subjected to an authorisation procedure, in the Uni-
ted Kingdom a voluntary approval system is in place. In
many other Member States no national regulation is in
place. Furthermore, the range of enzyme products and
enzyme applications permitted by national legislation
varies among those Member States that have a regula-
tion in place (4,30).
The following subsections provide a brief overview
on the regulatory contexts of the EU and the USA and
also touches on the JECFA – given their importance for
worldwide standards.
European Union
In the EU food additives are regulated by Council
Directive 89/107/EEC (28, amended by Directive 94/
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Table 3. Definitions of food additives and processing aids according to Directive 89/107/EEC (28)
Enzyme category Definitions
Food additives »means any substance not normally consumed as a food in itself and not normally used as a characteristic
ingredient of food whether or not it has nutritive value, the intentional addition of which to food for a
technological purpose in the manufacture, processing, preparation, treatment, packaging, transport or storage
of such food results, or may be reasonably expected to result, in it or its by-products becoming directly or
indirectly a component of such foods.« (Article 1.2)
Processing aids »means any substance not consumed as a food ingredient by itself, intentionally used in the processing of raw
materials, foods or their ingredients, to fulfil a certain technological purpose during treatment or processing
and which may result in the unintentional but technically unavoidable presence of residues of the substance
or its derivatives in the final product, provided that these residues do not present any health risk and do not
have any technological effect on the finished product.« (Article 1.2)
34/EC) on the approximation of the laws of the Member
States concerning food additives authorised for use in
foodstuffs intended for human consumption and Direc-
tive 95/2/EC (31, amended by Directives 96/85/EC, 98/
72/EC, 2001/5/EC, 2003/52/EC and 2003/114/EC) on
food additives other than colours and sweeteners. The
Community legislation on food additives is based on the
principle that only those additives that are explicitly
authorised may be used. Most food additives may only
be used in limited quantities in certain foodstuffs. If no
quantitative limits are foreseen, they must be used accord-
ing to good manufacturing practice, i.e. only as much as
necessary to achieve the desired technological effect.
Food additives may only be authorised if there is a
technological need for their use, if they do not mislead
the consumer, and if they present no hazard to the health
of the consumer. All food additives have to fulfil purity
criteria which are set out in detail in three Commission
directives: Directive 96/77/EC (32, amended by Direc-
tive 96/86/EC and Directive 2000/63/EC) for additives
other than colours and sweeteners.
Prior to their authorisation, food additives are eval-
uated for their safety by the Scientific Panel on food ad-
ditives, flavourings, processing aids and materials in con-
tact with food (AFC) at the European Food Safety Au-
thority (EFSA), which took over this responsibility from
the SCF in 2003. Guidance on safety evaluation is pro-
vided for food additives in general (33) and for enzymes
in particular (29). Requirements for toxicological data are
dealt with in the SCF Guidance on submissions for food
additive evaluations (33). This document includes some
guidance for additives produced from GMOs and also
refers to additional requirements for guidance docu-
ments on genetically modified food.
The 2001 guidance is, however, not intended to co-
ver additives of complex nature such as proteins. En-
zymes have thus been evaluated according to the SCF
Guidelines for the presentation of data on food enzymes
(29). These guidelines specify conditions of use, require-
ments for information, documentation and testing and
occasionally refer to concrete methods of testing. The
SCF guidelines focus on enzyme safety evaluation and
are considered as minimum requirements for informa-
tion to be supplied. These requirements refer to poten-
tial hazards and to the exposition of the enzyme prepa-
ration to the final consumer. With respect to hazards,
the guidelines mainly focus on toxicological require-
ments of enzyme preparations, on the safety of the
source organism and on unintended reaction products
in the food caused by enzymatic reactions in the final
foodstuff. Exposure deals mainly with the quantity of
enzymes consumed. Allergies or irritative effects are just
briefly mentioned by stating that these effects are con-
sidered primarily as occupational problems. Whereas the
SCF considers enzymes from (edible) plants or animal
species as posing no health problems, the toxicological
evaluation of enzymes from microbial sources is deemed
to be far more important. These toxicological tests should
investigate known toxins as well as unknown toxic com-
pounds that might be present in the enzyme prepara-
tion.
Exemptions from full testing requirements may be
justifiable if the production strain of an already tested
and approved enzyme preparation is substituted by a
mutant strain or in case of highly pure and specific en-
zyme preparations (which will become possible due to
the use of non-toxin-producing GMMs as hosts). Whether
the term »mutant strain« also include GMM is not speci-
fied. An enzyme preparation may even be accepted with-
out specific toxicological testing if the production organ-
ism has a long history of safety in food use, and belongs
to a species where no toxins are produced, and if the
particular strain is of well documented origin.
The main concern of the SCF regarding GMMs was
the possibility of unintentionally introducing toxin pro-
duction into the production organism. Furthermore, the
potential for causing secondary effects due to the ge-
netic rearrangements is also attributed: »each recombi-
nant product is to be evaluated on a case-by-case basis
considering the host, the vector and the insert and tak-
ing into account that the potential hazard from the final
product might be more than simply the sum of the sin-
gle elements« (29).
Any evaluation is confined to a particular enzyme
preparation described in the submission and cannot
»automatically be considered to cover other preparations
of the same enzyme prepared from other sources or by
other processes« (29). Accordingly, whether an enzyme
preparation is regarded as being new/different to an al-
ready approved enzyme preparation might be conside-
red on a case-by-case basis: e.g. if changes in the manu-
facturing and purification process resulted in an enzyme
preparation that does/does not substantially differ from
the original one. These changes may also include the re-
placement of the production strain.
So far, five food enzymes have been evaluated by
the SCF and one by the AFC (thrombin and fibrinogen
from cattle and pigs; urease from Lactobacillus fermen-
tum; papain from papaya; invertase from Saccharomyces
cerevisiae; chymosin from E. coli, Kluyveromyces lactis,
and Aspergillus niger; lactoperoxidase together with glu-
cose oxidase), and two enzymes, lysozyme (E1105) and
invertase (E1103), have been authorised as food additives
in the EU. Additives authorised under Directive 95/2/
EC are listed in the annexes to this Directive, which are
regularly updated. The specific guidelines on enzymes
of 1992 have not been updated so far but might never-
theless be replaced soon. In March 2005, the European
Commission circulated a »Draft Working Paper for a
Regulation of the European Parliament and of the Coun-
cil on Food Enzymes« (34). If this draft regulation be-
comes law, it will establish for the first time a harmo-
nised legislation on food enzymes, regardless of their
former differentiation into additives and processing aids.
However, it is yet too early to anticipate the changes the
proposed regulation will bring about. What nevertheless
seems to be clear is that a mandatory authorisation sys-
tem for enzymes that will include a safety evaluation
will be established.
Also recently, EFSA has circulated a »Draft Guid-
ance Document for the Risk Assessment of GMMs and
Their Derived Products Intended for Food and Feed Use«
(35). This document provides primarily guidance for the
risk assessment of GMMs and/or derived food and feed
within the framework of Regulation 1829/2003. How-
ever, food additives in the meaning of Directive 89/107/
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EEC produced from/with GMM are also covered. It seems
quite likely that this guidance will be used in addition
to or even instead of the SCF guidance of 1992 if en-
zymes from GMM have to be evaluated.
United States
Enzymes used in food are regulated by the US Food
and Drug Administration (FDA) under the Food, Drug
and Cosmetic (FDC) Act. Since 1958 the FDA has per-
ceived all enzymes as food additives and therefore sub-
jected to restrictions pertaining to food additives. In
general food enzymes may either be classified as (i) sub-
stances that are GRAS, (ii) substances that are not GRAS
which are defined as food additives, or (iii) substances
approved for use in food prior to September 6, 1958 by
the FDA or by the Department of Agriculture. The FDC
Act requires approval of food additives prior to market-
ing. GRAS substances, in contrast, are not subjected to
approval or notification to the FDA prior to marketing.
GRAS status may be based either on a history of safe
use in food prior to 1958 or on scientific procedures
which require the »same quantity and quality of evi-
dence as would be required to obtain a food additive
regulation«. GRAS status may be either affirmed by the
FDA or determined independently by qualified experts.
So far, about 50 enzymes have either been approved
as food additives or affirmed as GRAS by the FDA.
The regulatory status of food additives or substan-
ces affirmed as GRAS is established through a petition
process. Section 409(b)(2) of the FDC Act prescribes the
statutory requirements for food additive petitions. The
requirements for food additive petitions are discussed in
greater detail under title 21 of the Code of Federal Reg-
ulations (CFR) (part 171.1). However, the FDC Act does
not provide specific statutory requirements for GRAS af-
firmation petitions. The eligibility requirements for clas-
sification of a substance as GRAS are described under ti-
tle 21 in CFR 170.30 and for GRAS affirmation petitions
in CFR 170.35.
Detailed recommendations for enzymes are given in
a guidance document (36). These recommendations in-
tend to aid petitioners in assembling the chemical and
technological data currently considered appropriate for
a food additive or GRAS affirmation petition for an en-
zyme preparation. They cover data requirements in the
following areas: identity, manufacturing process, purity,
use, analytical methodologies, technical effects, and pro-
bable human exposure. The recommendations do not
address other data needs, such as those pertaining to
microbiological, toxicological and environmental consi-
derations. The extent of toxicological testing of food ad-
ditives depends on the assignment of a »concern level«,
on structural features and on an estimation of exposure.
Minimum testing requirements are recommended for
each concerned level as well as each structural and ex-
posure group (37). According to Zeman (30), North Ame-
rican enzyme manufacturers are using and FDA accepts
decision tree for evaluating enzymes as proposed by Pa-
riza and Johnson (26).
In order to evaluate the safety of an enzyme prepa-
ration, the petitioner and FDA are comparing the enzyme
to be assessed with other enzymes which have already
been approved or with those that have been »safely con-
sumed as part of the diet throughout human history«.
According to FDA »enzymes that have the same func-
tion and that are identified by the same name and EC
number often differ slightly in structure and properties
when they are obtained from different sources. For ex-
ample, the structure of an enzyme isolated from one
tissue (such as liver) of one animal species may differ
slightly from that of the same enzyme isolated from a
different tissue from the same species, or from the liver
of another animal species. In part, because of this varia-
bility, the diet routinely contains many thousands of dif-
ferent protein molecules« (38).
This approach is based on the concept of substantial
equivalence (in earlier documents also referred to as
substantial similarity), which is also used in the safety
evaluation of novel food. According to the definition if
»a new food or food component is found to be substan-
tially equivalent to an existing food or food component,
it can be treated in the same manner with respect to
safety. No additional safety concerns would be expect-
ed.« Consequently, the food or food component can be
concluded as safe as conventional food or food compo-
nent (39,40). This concept was further recommended by
international expert groups to be applied in the assess-
ment of »substances intentionally added to food.« For
example, a carbohydrase preparation and a protease pre
paration from Bacillus subtilis and Bacillus amylolique-
faciens were assessed to be substantially equivalent to
carbohydrase and protease enzymes from other micro-
organisms that had been evaluated and found to be safe
by FDA before (e.g. mixed carbohydrase protease prepa-
ration from Bacillus licheniformis, carbohydrases from
Rhizopus niveus, Rhizopus oryzae, and Aspergillus niger) (41).
FAO/WHO
About ten years before the SCF guidelines on en-
zyme safety evaluation were issued the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) had al-
ready been conducting safety evaluations of enzymes. The
JECFA is an international expert scientific committee
that serves as a scientific advisory body to FAO, WHO,
their Member States, and the Codex Alimentarius Com-
mission, primarily through the Codex Committee on Food
Additives and Contaminants and the Codex Committee
on Residues of Veterinary Drugs in Foods. It has been
meeting since 1956, initially to evaluate the safety of food
additives. For food additives, contaminants and natural-
ly occurring toxicants, the Committee: (i) elaborates prin-
ciples for evaluating their safety; (ii) conducts toxicologi-
cal evaluations and establishes acceptable daily intakes
(ADI) or tolerable intakes; (iii) prepares specifications of
purity for food additives; and (iv) assesses intake.
JECFA started evaluation of enzymes as early as
1971 and issued their first guidelines »General Specifica-
tions for Enzyme Preparations Used in Food Proces-
sing« in 1981 (42). These guidelines described require-
ments for technical data, source material, additives and
processing aids used in enzyme preparations as well as
for hygiene and contaminants. Since then the guidelines
have been further amended and supplemented (e.g. 43).
Right from the beginning the JECFA specification has
provided detailed description of methods for measuring
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enzyme activity, for the detection of antibiotic activity as
well as for testing for contaminating heavy metals and
microorganisms.
In 1991 the »General Considerations and Specifica-
tions for Enzymes from Genetically Manipulated Micro-
organisms« were published to supplement the »General
Specifications« (43). In this supplement the Committee
stated that in order to properly evaluate enzymes from
GMM it is considered very important to provide ade-
quate information on the source material, the »genetic
manipulation techniques«, and the fermentation and re-
covery process employed. In addition to these enzyme
specific guidelines the »Principles for the Safety Assess-
ment of Food Additives and Contaminants in Food« (44)
specified especially toxicological testing requirements.
In the revision of the »General Specifications« in
1989 the Committee concluded that a complete defini-
tion of all of the components of an enzyme preparation
can rarely, if ever, be achieved and that therefore the
identity and purity of preparations can best be ensured
by defining the manufacturing process and by establish-
ing criteria limiting the presence of contaminants and
possible toxic metabolites derived from the source or
contaminating organisms. Consequently, the Committee
considered that the source organism should be defined
not only by genus and species but also by strain or vari-
ant and that the culture conditions employed in manu-
facturing should be the same as those used for prepar-
ing the batches subjected to toxicity testing (45). In the
view of the Committee, differences in either the strain of
the source organism or the conditions under which it
was cultured would imply a change in the composition
of the preparation and would therefore require a re-eva-
luation (45).
The requirements to define the strain of the produc-
tion organism were loosened in 1999 when it was con-
cluded that citation of genus and species of host orga-
nisms is usually adequate for those that had been deter-
mined to be safe and suitable. The reason given for this
amendment was that identification at the strain level
might impose unnecessary constraints on the develop-
ment of production microorganisms used to produce food-
-grade enzymes.
The guidelines including all amendments and sup-
plements until 1999 were published in an updated ver-
sion of the »Compendium of Food Additive Specifica-
tions« (Annex 1, originally published as FAO Food and
Nutrition Papers, 52). In June 2001, the Committee re-
vised their guidelines on enzyme preparations again
(46,47). Revisions included threshold limits for heavy
metals and contaminating microorganisms, testing re-
quirements for mycotoxins, and the need for evaluation
of the allergic potential. Although the task of JECFA is
limited to additives (according to self-portrayal), evalua-
tion practice does not distinguish between additives and
processing aids. The Committee normally evaluates dos-
siers submitted by the manufacturers. The toxicological
monographs are based on working papers which are
themselves often based on proprietary unpublished re-
ports. These reports are voluntarily submitted to the
Committee by the manufacturers and in many cases they
represent the only safety data available on these sub-
stances. All these studies are available to the Committee
when it makes its evaluations.
An (temporary) approval of enzymes from the Com-
mittee results either in the allocation of an ADI or –
more often – in general statements that, e.g. in the opi-
nion of the Committee, the enzyme preparation does not
represent a hazard to health (therefore and for reasons
stated in the individual evaluations, the establishment of
an ADI expressed in numerical form is not deemed ne-
cessary). The evaluation procedure by the JECFA is nei-
ther mandatory nor does an approval or rejection have
any legal status; the results of the evaluations are ne-
vertheless widely acknowledged in many states all over
the world. So far, 68 enzyme preparations have been eva-
luated by the JECFA.
Industry perspective
As the safety evaluation of enzymes used as pro-
cessing aids is not regulated in most EU Member States
it is up to the industry to design an appropriate process
of safety evaluations. Industry acknowledges the guide-
lines for safety evaluations issued by JECFA (48), SCF
and the UK Committee on the Toxicity of Chemicals in
Foods, Consumer Products and the Environment (COT)
(49) and has come up with their own recommendations
as well (48).
According to AMFEP it is more appropriate to ap-
prove the source rather than each particular enzyme ac-
tivity, as an enzyme preparation also consists of accom-
panying substances which highly depend on the source
organism. Therefore, enzymes are obtained from non-
-pathogenic and non-toxicogenic microorganisms grown
on materials which do not contain components which
might be hazardous to health.
In order to further facilitate the evaluation of the pro-
duction organism, which is crucial in the view of AMFEP
as mentioned above, AMFEP established criteria to de-
velop a list of microorganisms that can be recognized as
safe for food production (50). AMFEP generally admits
the importance of evaluating the possible impact on safe-
ty of enzyme preparations in case of strain improve-
ments or when production conditions are altered on a
case-by-case basis.
Comparison of safety requirements
Although the requirements for safety evaluations in
guidance documents and the scientific literature differ,
the overall structure is fairly similar and includes:
¿ Basic technical data on the enzyme itself, as the
active compound of the preparation
¿ Information on the source material; special atten-
tion is given to microbial sources
¿ Substances added to the enzyme isolate (or used
during processing)
¿ Possible contaminants (microorganisms, heavy me-
tals, toxins) present in the final enzyme prepa-
ration.
¿ In the case of GMMs additional information is re-
quired on the host organism, the donor organism,
the vector, or introduced DNA.
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Enzymes are identified by their catalytic activity in
all guidelines and provisions. In general, guidelines and
provisions do not describe the requirements precisely.
Thus, much is left to interpretation. Most detailed phy-
sicochemical information on the enzyme is required by
the FDA (enzymatic function, mode of action, substrate
specificity, molecular mass, isoelectric point, kinetic pro-
perties, specific activity, temperature, pH, inorganic ions).
In general, more detailed information is requested in case
of GMM and for potential contaminants.
FDA requires the most detailed information on en-
zymes from GMM, including detailed technical data on
the enzyme itself, on structural modifications, on the
GMM (genetic stability, growth properties), vector, in-
troduced DNA, donor organism as well as detailed in-
formation on the manufacturing and purification pro-
cess. The JEFCA guidelines also require more detailed
technical data on enzymes from GMM, whereas the SCF
asks in greater detail on the vector. Only JECFA and
FDA point to antibiotic resistance genes which might be
unintentionally present in the final enzyme preparation.
FDA also specifies a list of parameters which should be
used in comparative analysis to justify substantial equi-
valence (enzymatic activity, kinetic parameters, amino
acid composition, amino sugar composition, amino acid
sequence, molecular mass, isoelectric point, gel migra-
tion, chromatographic properties).
SCF describes basic toxicological requirements, which
are toxicological tests to be performed and possible ex-
emptions from testing within the enzyme guidelines. The
JECFA laid down general principles for toxicological test-
ing in a separate publication. Particular requirements for
toxicological testing primarily depend on the nature of
the microbial source, e.g. if it is a microbe that also na-
turally occurs in food, if it is a GMM, etc. Unlike the
contested proposals for toxicity testing in the scientific
literature (see preceding section), toxicity endpoints sug-
gested in guidance documents are fairly similar. SCF and
JECFA ask for a 90-day subchronic toxicity test along
with mutagenicity tests on bacteria and an in vitro test
for chromosomal aberration (see Table 4). AMFEP does
not specify particular toxicity endpoints for food en-
zymes.
Potential allergenic properties are mentioned by the
SCF only in the introduction, whereas no requirements
are given in the guidelines themselves. Allergenic pro-
perties are mentioned by the JECFA only in case of
GMM.
Other differences are:
¿ Only SCF includes requirements on data for the
manufacturing process, the usage and stability in
food.
¿ Detailed descriptions of methods or references for
methods to be used in testing and data produc-
tion are given by both SCF and JEFCA.
¿ The AMFEP guidance does not in general include
detailed description of requirements. However,
AMFEP does acknowledge the guidelines from
JECFA, SCF and COT.
¿ Safety approvals are often confined to particular
enzyme preparations (SCF). Changes in the pro-
duction process or application of genetic engi-
neering lead to a re-evaluation on a case-by-case
basis. Waivers from toxicological testing are also
dealt with on a case-by-case basis.
¿ FDA takes into account long-term experience with
certain enzymes. A GRAS status may be assigned
to such enzymes.
If the recently drafted EFSA »Guidance Document
for the Risk Assessment of Genetically Modified Micro-
organisms and Their Derived Products Intended for Food
and Feed Use« (34) were applied to food enzymes from
GMM as well, this would establish detailed information
requirements for characterisation of the enzyme protein
similar to those proposed by FDA including amino acid
sequence and post-translational modifications.
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Table 4. Toxicity endpoints proposed for food enzymes derived from microorganisms
Toxicological endpoints/References 27 26 29 34 48
Acute toxicity (oral) n.r. Ya n.r. n.r. n.r.d
Repeated dose toxicity (on rodents) 90-day 14–91 daya 90-day 28-day 90-dayd
Mutagenicity
in vitro bacteriological test Y n.r.b Y c Yd
in vitro non-bacteriological test Y n.r.b Y Yd
Exemptions n.sp. possible e f n.i.
Key: n.i. not investigated, n.r. not required, n.sp. not specified, Y required
aEither acute or repeated dose tests suggested on a case-by-case basis, depending largely on the species of the host organism and
consideration of the nature of toxins that could theoretically be present (e.g. mycotoxin or bacterial enterotoxin). According to
Pariza and Johnson (26) bacterial toxins are acute toxins and are produced by a few species only
bRelevant only in case of new enzyme types
cDepending on the outcome of 28-day study additional tests may be required
dNot explicitly required but generally accepted in recent enzyme evaluations
eIf the production microorganism has a long history of safety in food use, and belongs to a species where no toxins are produced,
and the particular strain is of well documented origin, acceptance of enzyme preparation without specific toxicological testing may
be justified. In case of non-toxin producing GMO: if high purity and specificity of the enzyme product could be demonstrated, full
toxicity testing may not be needed
fIf both the GMM and the protein have a history of safe consumption by humans and animals, specific toxicity testing might not be
required
Toxicity relevant information would include homo-
logy comparisons to proteins known to cause adverse
effects, information on stability of the protein under pro-
cessing and storage conditions, and the expected treat-
ment of the food and testing for resistance to proteolytic
enzymes. Toxicity testing would include a 28-day oral
toxicity study – additional studies would depend on the
outcome of the 28-day study. Exemptions from toxicity
testing might be justified if both the GMM and the pro-
tein have a history of safe consumption by humans. Com-
pared to the other guidance documents, the EFSA Draft
would put much more emphasis on allergenicity assess-
ment, including homology comparison, digestibility test-
ing and might even include in vitro tests with serum from
allergic patients.
This guidance is, however, not laid out for indus-
trial enzymes and certain enzyme specific information
requirements, such as for additives in the enzyme prep-
aration, hygiene (total viable counts, production strain),
contaminants including thresholds (heavy metals, mi-
crobes, antibiotic activity in enzyme preparation, pres-
ence of mycotoxins) are not included. Hence, it is likely
that for food enzymes additional guidance needs to be
provided by EFSA.
New Methods in Enzyme Production
The application of genetic engineering techniques in
enzyme manufacturing is pushing up the exploitation of
new enzymes and the development of new enzyme pro-
perties.
Enzyme yield has been improved – among other
factors – by the use of strong expression or multi-copy
systems (51,52). Enzymes that were not accessible be-
fore, e.g. because it would not have been feasible to set-
-up a production process with their source organisms,
can now be cloned into and produced from a well-
-known host organism. Thereby, enzymes from almost
any source in nature become accessible exhibiting un-
usual properties such as extreme thermostability. This
includes thermophilic and psychrophilic microbes and
even non-culturable microbes (53,54).
Combinatorial approaches of rational protein design
and directed evolution methods turn out to efficiently
alter the properties of enzymes; enzyme stability, cata-
lytic mechanism, substrate specificity and range, surface
activity, folding mechanisms, cofactor dependency, pH
and temperature optima, and kinetic parameters have
been successfully modified (e.g. 55,56). Even enzyme ac-
tivities were switched (57). Protein shuffling and related
techniques dramatically increase the variability of en-
zymes and might lead to enzymes not present in nature
so far (e.g. 58,59). Apart from manufacturing enzymes
from microorganisms plants are also investigated for the
production of enzymes (60). Furthermore, enzymes can
be chemically modified, e.g. by incorporation of cofac-
tors, or chemical glycosylation (61).
Since the marketing of the first genetically modified
industrial enzyme about 15 years ago and the subse-
quent development of these methods for modifying en-
zyme structure during the last 10 years, the number of
available enzymes has dramatically increased and en-
zyme properties have been enhanced significantly. For
instance, between 1993 and 1997 more than 130 fungal
enzyme genes were cloned at Novozymes only (53).
Challenges for Food Enzyme Regulation and
Safety Evaluation
From the review above several challenges for both
further development of food enzyme regulation and for
safety evaluation can be identified. These challenges can
be attributed to differences in both existing legislation
and in requirements for safety evaluation, to prevalent
scientific uncertainties and to the introduction of new
production technologies, especially genetic engineering.
Regulatory aspects
Whether enzymes are categorised as processing aids
or as additives and whether the definitions for both cate-
gories differ among countries is not important only to
bureaucrats. In the EU, for instance, only food additives
are covered by harmonised legislation and are required
to undergo a pre-market approval procedure. This might
not only be relevant for trade liberalisation but also in
terms of consumer safety and perhaps of occupational
safety as well. For, if no pre-market approval is manda-
tory – neither is safety evaluation. Consequently, safety
evaluation of food enzymes used as processing aids
would be a voluntary task depending on the particular
manufacturer only. Although internal industry guidelines
for safety of enzyme preparations and safe handling of
enzymes exist, this might not be considered sufficient as
both consumer awareness of food production methods
and scepticism towards the food industrial system have
been increasing considerably. In the EU, this picture might
soon change though, if a new regulation on food en-
zymes along with a mandatory safety evaluation is actu-
ally established.
Another question is whether occupational health
risks in manufacturing and handling of food enzymes
are actually covered by harmonised EU legislation. In
case of technical enzymes occupational health risks are
dealt with under harmonised chemical legislation. If a
new enzyme is marketed, the pre-market application will
also include information on occupational health issues.
Similarly, certain occupational health aspects have to be
considered if applying for an authorisation of a new feed
enzyme under harmonised EU legislation. In the ab-
sence of harmonised EU legislation for food enzymes that
are used as processing aids only, they would thus be
subjected to hazard classification and labelling accord-
ing to chemical legislation. Whereas the manufacturing
processes and associated risks of most industrial en-
zymes are similar it would have to be clarified whether
this regime establishes different degrees of scrutiny of
occupational risks. Given that about 90 enzymes pre-
sently manufactured by AMFEP member companies are
solely used in food industry, this might be a relevant
question to clarify (1).
Occupational and consumer safety
Industry has achieved a lot in reducing health risks
for workers. However, there are still reports on occupa-
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tional health problems. For instance, British authors re-
ported an outbreak of asthma, at least equal in size to
the numbers reported in the 60s, in a modern European
factory which has used exclusively encapsulated en-
zymes (62,63). A survey revealed that enzyme sensitisa-
tion and work-related respiratory symptoms were posi-
tively correlated with airborne enzyme exposure. With
bakers the number of workers that have to leave their
job because of work-related problems is still increasing
(64). This kind of reports keep the discussion ongoing
and urge for a critical review and improvement of the
safety precaution measures to be established.
Following contradicting evidence on skin sensitizing
properties of enzymes, this calls upon further research.
With respect to enzymes from GMM it has to be
mentioned that there are currently no reports on specific
problems caused by these enzymes; they appear to have
the same sensitising potential and are capable of sensi-
tising exposed employees at the same rate as traditional
enzymes (65). However, special attention might be ap-
propriate. Changes in the amino acid sequence of en-
zymes, their structure, or properties such as thermosta-
bility might change allergenic properties. This is probably
less important for occupational health as industry vo-
luntarily labels and accordingly handles the enzymes as
respiratory sensitizers. As enzymes might also be pre-
sent in food it could nevertheless be important for con-
sumers. So far, a possible allergenicity of food enzymes
was a rather neglected issue in enzyme safety evalua-
tions (30,46,47). A recent draft guidance document sug-
gests a change in perception (34) – at least for enzymes
from GMM. If this guidance document is to be used for
enzyme evaluations the allergenic properties of new en-
zymes will have to be evaluated in light of their simila-
rities to known enzymes, as well as food and environ-
mental allergens. Such assessment procedures were
originally introduced for foods derived from genetically
modified crops (66). These procedures are increasingly
contested for evaluating food from GMOs (reviewed in
24) but might nevertheless still be appropriate for food
enzymes. At least well characterised and purified en-
zyme isolates would perhaps not allow for a high per-
centage of other proteins to be present.
As the use of enzymes expands into new areas there
is also a risk of exposure of the general population,
which differs from the current situation. And if enzymes
are increasingly used for cosmetic and other consumer
product uses, it becomes imperative to understand how
people can be exposed to enzymes, the level of exposure
and the risk for sensitisation.
Further research on understanding how enzymes act
as allergens, linked with an understanding of how indi-
viduals become sensitised to enzymes is therefore im-
portant for the continued control of occupational and
non-occupational disease caused by enzymes (67).
With respect to otherwise toxic properties of en-
zyme preparations, it seems that present safety evalua-
tion approaches seem to work well to identify both criti-
cal amounts of toxins inadvertently present in the enzyme
isolate and possible unknown toxic effects including the
enzyme protein itself. Furthermore, it has to be acknow-
ledged that the use of GMMs has the potential to im-
prove product safety by reducing the number of pro-
duction organisms to a small set of well characterised
strains that sometimes have safely been used in enzyme
manufacturing and even in food processing for decades.
This seems to be important for both occupational risks
and for consumer safety.
The application of genetic engineering techniques
resulted in increased variability and modified properties
of enzymes such as thermo- and pH-stability. Further-
more, enzymes from exotic sources might be used in
food for which there is no prior experience of exposure
to humans. For this reasons it might be premature to
generally relax the requirements for toxicity testing as
demanded by Pariza and Johnson (26).
Furthermore, as shown in the sections above, there
are differences in the requirements for safety evalua-
tions of food enzymes among countries and scientific
committees alike, e.g. toxicity endpoints. These differ-
ences are indicators of scientific uncertainties and point
to a need for either clarification and/or scientific re-
search. This would be helpful to clarify the relevance of
endpoints and test methods contested in the scientific li-
terature and in guidance documents for industry. There-
by, consistency in safety evaluation would be improved
and unnecessary testing avoided.
The challenges mentioned above will most likely con-
cern regulators and industry alike. The introduction of
an EU harmonised legislation on food enzyme would
offer an opportunity to reconsider regulatory approaches
and scope and requirements for safety evaluations as
well. Legislation and the implantation process will take
place under critical observation and perhaps involve-
ment of well-informed consumer and environmental
groups. Scientists should also be aware of this process
and might be interested and willing to contribute in or-
der to arrive at a sound and reasonable regulatory frame-
work. Ideally, further research will be conducted to clar-
ify the open questions indicated.
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